LEADER 03660nam  22006014a 450 
001 9910825818903321
005 20240404154218.0
010   $a1-281-86767-5
010   $a9786611867676
010   $a1-86094-852-9
035   $a(CKB)1000000000538136
035   $a(SSID)ssj0000222521
035   $a(PQKBManifestationID)11210311
035   $a(PQKBTitleCode)TC0000222521
035   $a(PQKBWorkID)10171057
035   $a(PQKB)11411310
035   $a(MiAaPQ)EBC1681675
035   $a(WSP)00001804    
035   $a(Au-PeEL)EBL1681675
035   $a(CaPaEBR)ebr10255667
035   $a(CaONFJC)MIL186767
035   $a(OCoLC)815742126
035   $a(EXLCZ)991000000000538136
100   $a20080619d2008      uy         0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aPlatelets in cardiovascular disease /$feditor, Deepak L. Bhatt
205   $a1st ed.
210   $aLondon $cImperial College Press$d2008
215   $axv, 218 p. $cill
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a1-86094-826-X 
320   $aIncludes bibliographical references and index.
327   $a1. Platelet biology: the role of platelets in hemostasis, thrombosis and inflammation / Richard C. Becker -- 2. Thromboxane antagonists / Brian R. Dulin and Steven R. Steinhubl -- 3. Glycoprotein IIb/IIIa inhibitors / Sam J. Lehman, Derek P. Chew and Harvey D. White -- 4. ADP receptor antagonists / Juhana Karha and Christopher P. Cannon -- 5. Monitoring antiplatelet therapy / Paul Harrison and Alan D. Michelson -- 6. Platelet genomics / Brian K. Jefferson, Kandice Kottke-Marchant and Eric J. Topol -- 7. Future strategies for the development of antiplatelet drugs / Robert A. Harrington.
330   $aPlatelets in Cardiovascular Disease provides an in-depth and current coverage of relevant platelet biology and antiplatelet therapy that is in clinical use today and potentially for the future. The book provides a succinct overview of the critical role of platelets in cardiovascular medicine. Cardiovascular disease is the leading cause of mortality worldwide, and recent research has found that the platelet is central to the genesis of heart attacks and stroke as well as many of the complications of angioplasty and bypass surgery. An explosion of knowledge of the biology of platelets has established their important role in the formation of blood clots and, perhaps more intriguingly, their role as inflammatory cells. This growth in information has been paralleled by the development of several drugs that can interfere with platelet action and thereby improve patient outcomes. Indeed, several antiplatelet drugs already in development may ultimately lead to marked advances in both the treatment and prevention of cardiovascular disease. Drawing upon a panel of international experts, Platelets in Cardiovascular Disease delivers a concise yet thorough review of the major developments in antiplatelet therapy. Practicing clinicians as well as those involved in the development of new antithrombotic therapies will find the book interesting and useful. 
606   $aCardiovascular agents
606   $aBlood platelets
606   $aCardiovascular system$xDiseases
615  0$aCardiovascular agents.
615  0$aBlood platelets.
615  0$aCardiovascular system$xDiseases.
676   $a615/.71
701   $aBhatt$b Deepak L$01612622
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910825818903321
996   $aPlatelets in cardiovascular disease$94105001
997   $aUNINA